about
Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms.The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazoleEfficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic reviewMolecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.Adjunctive aripiprazole for bupropion-resistant major depression.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Adjunctive aripiprazole in bipolar I depression.
@en
Adjunctive aripiprazole in bipolar I depression.
@nl
type
label
Adjunctive aripiprazole in bipolar I depression.
@en
Adjunctive aripiprazole in bipolar I depression.
@nl
prefLabel
Adjunctive aripiprazole in bipolar I depression.
@en
Adjunctive aripiprazole in bipolar I depression.
@nl
P2860
P356
P1476
Adjunctive aripiprazole in bipolar I depression.
@en
P2093
Kenneth N Sokolski
P2860
P356
10.1345/APH.1H294
P407
P577
2006-12-26T00:00:00Z